ABCL
Price
$3.69
Change
-$0.05 (-1.34%)
Updated
Jun 27, 12:47 PM (EDT)
Capitalization
1.12B
46 days until earnings call
PMVP
Price
$1.05
Change
-$0.03 (-2.78%)
Updated
Jun 27, 01:07 PM (EDT)
Capitalization
56.11M
41 days until earnings call
Interact to see
Advertisement

ABCL vs PMVP

Header iconABCL vs PMVP Comparison
Open Charts ABCL vs PMVPBanner chart's image
AbCellera Biologics
Price$3.69
Change-$0.05 (-1.34%)
Volume$450
Capitalization1.12B
PMV Pharmaceuticals
Price$1.05
Change-$0.03 (-2.78%)
Volume$100
Capitalization56.11M
ABCL vs PMVP Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. PMVP commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and PMVP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ABCL: $3.74 vs. PMVP: $1.08)
Brand notoriety: ABCL and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 90% vs. PMVP: 39%
Market capitalization -- ABCL: $1.12B vs. PMVP: $56.11M
ABCL [@Biotechnology] is valued at $1.12B. PMVP’s [@Biotechnology] market capitalization is $56.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABCL and PMVP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 6 TA indicator(s) are bullish while PMVP’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 6 bullish, 4 bearish.
  • PMVP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than PMVP.

Price Growth

ABCL (@Biotechnology) experienced а +7.78% price change this week, while PMVP (@Biotechnology) price change was -1.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.94%. For the same industry, the average monthly price growth was +39.30%, and the average quarterly price growth was +17.52%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

PMVP is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+9.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.12B) has a higher market cap than PMVP($56.1M). ABCL YTD gains are higher at: 27.645 vs. PMVP (-28.477). PMVP has higher annual earnings (EBITDA): -87.97M vs. ABCL (-211.2M). ABCL has more cash in the bank: 605M vs. PMVP (160M). PMVP has less debt than ABCL: PMVP (1.11M) vs ABCL (67.8M). ABCL has higher revenues than PMVP: ABCL (23.1M) vs PMVP (0).
ABCLPMVPABCL / PMVP
Capitalization1.12B56.1M1,989%
EBITDA-211.2M-87.97M240%
Gain YTD27.645-28.477-97%
P/E RatioN/AN/A-
Revenue23.1M0-
Total Cash605M160M378%
Total Debt67.8M1.11M6,130%
TECHNICAL ANALYSIS
Technical Analysis
ABCLPMVP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 5 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 10 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FANAX44.14N/A
N/A
Fidelity Advisor Energy A
MGRBX43.17N/A
N/A
MFS International Growth B
TEFTX8.88N/A
N/A
Templeton Foreign C
BRUKX15.97N/A
N/A
MFS Blended Research Value Equity R2
DLCIX22.28N/A
N/A
Dana Large Cap Equity Institutional

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-1.58%
CRSP - ABCL
62%
Loosely correlated
-0.17%
RXRX - ABCL
59%
Loosely correlated
+4.65%
ABSI - ABCL
57%
Loosely correlated
-1.81%
VCYT - ABCL
56%
Loosely correlated
+1.36%
BEAM - ABCL
55%
Loosely correlated
+2.27%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
-0.92%
CLLS - PMVP
39%
Loosely correlated
-0.81%
XNCR - PMVP
39%
Loosely correlated
-1.87%
VCEL - PMVP
37%
Loosely correlated
-3.88%
COGT - PMVP
37%
Loosely correlated
+3.68%
ABCL - PMVP
36%
Loosely correlated
-1.58%
More